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CD25, the α-chain of the IL-2R (IL-2R α), defines a population of CD4+ T 
cells that is present in the thymus and peripheral lymphoid organs and has the 
capacity to suppress the proliferation of conventional T cells and to block the 
development of autoimmune disease (Sakaguchi et al., 1995; Shevach et al., 
2001). These cells are referred to as CD25+CD4+ regulatory T cells (T regs).  
CD25+CD4+ T regs are able to suppress systemic and tissue-specific, immune-
mediated diseases and are thought to play a key role in maintaining self-olerance 
(Sakaguchi et al., 1995; Shevach et al., 2001).  At the cellular level it has been 
shown that CD25+CD4+ T regs can block the proliferation and function of both 
CD4+ and CD8+ T cells (Piccirillo and Shevach, 2001; Sakaguchi et al., 1995; 
Shevach et al., 2001; Thornton and Shevach, 1998).  A number of molecules 
have been implicated in CD25+CD4+ regulatory T cell function, most prominently 
cytokines such as IL-10 and the inhibitory surface receptor, CTLA-4 (Asseman et 
al., 1999; Nakamura et al., 2001; Powrie et al., 1996; Read et al., 2000; 
Takahashi et al., 2000).  
As is the case for conventional T cell populations, CD25+CD4+ regulatory 
T cell development is dependent on the thymus.  These cells start to appear in 
the peripheral lymphoid organs between days 3 and 10 of age in the mouse, 
suggesting that there is a burst of CD25+CD4+ T reg generation and 
dissemination that occurs during a defined developmental window (Asano et al., 
1996; Itoh et al., 1999).  It is becoming clear that Ag plays an important role in 
driving CD25+CD4+ regulatory T cell development. Recent studies have shown 
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that TCR transgenic CD4+ T cells can adopt regulatory cell phenotype and 
effector function when they encounter self-Ag in the thymus (Jordan et al., 2001; 
Jordan et al., 2000).  Traditionally, Ag encounter in the thymus has been thought 
to induce the deletion of autoreactive T cells (Vonboehmer, 1990). The rules for 
when self-Ag triggers thymocytes to undergo apoptosis vs CD25+CD4+ T reg 
differentiation remain to be fully defined. However, consistent with the 
observation that self-Ag is a driving force in regulatory T cell development, 
peripheral populations of these cells are enriched for autoreactive cells 
(Romagnoli et al., 2002). 
The generation and maintenance of CD25+CD4+ regulatory T cells also 
appears to be under the control of costimulatory molecules and growth factors.  
Genetic ablation of CD28 or B7 molecules that function as ligands for this 
receptor, leads to a marked decrease in CD25+CD4+ T reg numbers (Salomon et 
al., 2000).  Although CD28 or B7 deficiency alone is not sufficient to promote 
autoimmunity, these mutations do accelerate disease in some mouse models of 
autoimmune disease (Salomon et al., 2000).  Recent work has also shown that 
the CD40/CD40 ligand system is required to establish and maintain CD25+CD4+ 
T regs (Kumanogoh et al., 2001).  The molecular mechanisms by which these 
costimulatory signals promote CD25+CD4+ T reg development remain unknown.  
The seminal observation that the α-chain of the IL-2R (Piccirillo and 
Shevach, 2001) is constitutively expressed on CD25+CD4+ T regs (Akashi et al., 
1997; Asano et al., 1996; Hall et al., 1990; Wolf et al., 2001) suggested 
immediately that IL-2 might be an important growth factor for these cells.  Recent 
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studies have proven that functional CD25+CD4+ T regs are produced in the 
absence of IL-2, indicating that this cytokine is not required for the development 
of these cells (Almeida et al., 2002; Furtado et al., 2002).  However, CD25+CD4+ 
T reg numbers are significantly reduced in the peripheral lymphoid organs of 
mice that lack IL-2 or an IL-2R compared with wild-type cells (Almeida et al., 
2002; Furtado et al., 2002; Malek et al., 2002).  Furthermore, adoptive transfer of 
wild-type CD25+CD4+ T regs can prevent the autoimmune disease and 
inflammatory bowel disease that spontaneously develop in the absence of IL-2 
(Malek et al., 2002).  These findings indicate that one mechanism by which IL-2 
mediates its tolerogenic and immune-modulatory effects is by maintaining 
CD25+CD4+ T reg homeostasis.  
The molecular basis of the IL-2 dependence of CD25+CD4+ T regs has not 
yet been addressed. In conventional T cells, the effects of IL-2 are elicited by at 
least two major signaling pathways.  One leads to the activation of the 
serine/threonine kinase, AKT, and up-regulation of antiapoptotic molecules such 
as Bcl-2 and Bcl-xL and is required for T cell survival (Van Parijs et al., 1999b).  
The other leads to the activation of STAT5 and is required for T cell proliferation 
and differentiation; it may also stimulate the expression of antiapoptotic 
molecules (Moriggl et al., 1999a; Moriggl et al., 1999b; Van Parijs et al., 1999b).  
In this study we have investigated the roles of these IL-2 signaling pathways in 
CD25+CD4+ T reg biology. Using a variety of genetic approaches, we show that 
STAT5 activation is required to obtain normal numbers of CD25+CD4+ T regs and 
to prevent the development of autoimmunity, but that Bcl-2 expression is 
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dispensable for these activities. Our findings uncover an essential function for 
STAT5 in CD25+CD4+ T reg homeostasis and the maintenance of self-tolerance.  
 
2. Materials and Methods 
Mice  
Bcl-2 knockout, Bcl-2 transgenic (strain 25), IL-2 knockout, Janus kinase 3 
(Jak3) knockout, and recombinase-activating gene 1 (RAG1) knockout mice (all 
on a C57BL/6 background) were purchased from The Jackson Laboratory (Bar 
Harbor, ME). IL-2Rβ knockout mice were a gift from Dr. Y. Refaeli (University of 
California, San Francisco, CA).  STAT5a/b double knockout mice were generated 
by the laboratory of Dr. J. Ihle (St. Jude’s Hospital, Nashville, TN), and were 
given to us by Dr. M. Socolovsky (Whitehead Institute, Cambridge, MA).  We 
refer to these double knockout mice as STAT5 deficient in the text. To create IL-2 
knockout mice that constitutively expressed Bcl-2 in T cells, IL-2+/- mice were 
bred with Bcl-2 transgenic (Tg) mice to create IL-2+/-xBcl-2 Tg mice.  These were 
then interbred to obtain IL-2-/-xBcl-2 Tg and control mice. Mice were genotyped 
using PCR protocols provided by The Jackson Laboratory.  STAT5a/b 
heterozygous mice were bred for two generations with RAG1-/- mice to generate 
Stat5a/b+/-xRAG1-/- and were then interbred to obtain Stat5a/b-/-xRAG1-/- and 
control mice.  All mice were housed and bred under specific pathogen-free 
conditions at Massachusetts Institute of Technology and were between 6 and 9 
wk old when used in the experiments described here. 
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Abs and Flow Cytometry  
The following Abs used in this study were purchased from BD PharMingen 
(San Diego, CA): anti-CD4, -CD8a, -CD25, -CD62L, and -Bcl-2, as well as the 
Fc-blocking reagent anti-CD16/CD32. Magnetic beads against CD4, CD8, and 
B220 were purchased from Miltenyi Biotec (Auburn, CA).  
For surface staining experiments, cells were blocked with anti-CD16/CD32 
for 10 min on ice and washed once with PBS.  After blocking, cells were stained 
with anti-CD4, anti-CD25, or anti-CD62L Abs for 20 min on ice and washed with 
PBS before analysis.  Data were analyzed using CellQuest software (BD 
Biosciences, Mountain View, CA).  Intracellular Bcl-2 was determined using the 
Cytofix/Cytoperm Plus Kit (with GolgiStop) from BD PharMingen (San Diego, CA) 
according to the protocol provided by the company.  
 
T Reg Purification and Functional Assays  
CD25+ and CD25- CD4+ cell populations were purified using a two-step 
protocol. Lymph node and spleen cell suspensions were enriched for CD4+ T 
cells by incubating with magnetic anti-CD8a, -CD11b, -CD11c, and -B220 
microbeads (Miltenyi Biotec) and passing them through an AUTO-MACS 
magnetic column (Miltenyi Biotec). The resulting population was stained for CD4 
and CD25. CD4+ CD25+ and CD4+ CD25- populations were then sorted using a 
MoFlo cell sorter (Cytomation, Fort Collins, CO). The resulting populations were 
>95% enriched for the desired cell type.  
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To measure regulatory T cell activity, increasing numbers of CD25+CD4+ 
cells were cultured with 1 x 105 wild-type CD25-CD4+ cells in the presence of 1 
µg/ml anti-CD3 and 2 x 105 irradiated syngeneic spleen cells in a 200-µl volume. 
Proliferation was assayed after 72 h of culture by [3H]thymidine incorporation.  In 
adoptive transfer experiments, between 2 x 105 and 5 x 105 T regs purified from 
wild-type C57BL/6 mice were injected i.p. into 3-day-old STAT5a/b+/- and 
STAT5a/b-/- mice.  These mice were analyzed between 8 and 12 wk of age.  
 
Generation of Inducible STAT5 Transgenic Mice  
A conditional allele of STAT5 (STAT5ER) was created by fusing a 
constitutively active allele of STAT5 (STAT5CA) (Onishi et al., 1998) in-frame 
with a mutated version of the human estrogen receptor, a gift from G. Evan 
(University of California, San Francisco, CA). STAT5ER was subsequently 
introduced into a green fluorescence protein (GFP)-expressing bicistronic 
retroviral vector (MIG) (Van Parijs et al., 1999b). Both control (MIG) and 
STAT5ER-expressing retroviruses were generated by transient transfection of 
293.T cells as described previously (Van Parijs et al., 1999b).  To test the activity 
of STAT5ER, we infected activated CD4+ T cells with MIG, MIG-STAT5ER, or 
MIG-STAT5CA, a retrovirus that expresses a constitutively active form of STAT5 
(Van Parijs et al., 1999b).  Infected T cells were cultured for 48 h in the presence 
or the absence of 100 nM 4-hydroxytamoxifen (OHT; Sigma-Aldrich, St. Louis, 
MO) (Kelly et al., 2002).  Active STAT5 was detected by gel-shift assay (data not 
shown) (Van Parijs et al., 1999b). STAT5 transcriptional activity was detected by 
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assaying cis levels by Western blot (data not shown) (Moriggl et al., 1999b).  
STAT5 biological activity was assayed by measuring proliferation by 
[3H]thymidine incorporation (Kelly et al., 2002).  
To generate inducible STAT5 mice, bone marrow cells derived from 
cohorts of 5–10 wild-type or IL-2-deficient mice treated with 5 mg of 5-fluorouracil 
were cultured in the presence of IL-3 (20 ng/ml), IL-6 (50 ng/ml), and SCF (50 
ng/ml) and infected with retrovirus.  The efficiency of bone marrow infection in the 
three separate experiments performed was 34, 59, and 48% for MIG and 43, 69, 
and 31% for STAT5ER.  Infected bone marrow cells were used to reconstitute the 
immune systems of 6-wk-old lethally irradiated (1200 rad in two doses separated 
by 4 h) female C57BL/6 mice. Bone marrow chimeras were used in experiments 
at least 8 wk after injection to allow full reconstitution of the immune system.  To 
induce STAT5 activity, mice were treated every 2–3 days with 1 mg of OHT.  
OHT was dissolved in ethanol to produce a 100 mg/ml solution, which was then 
diluted to 10 mg/ml in autoclaved sunflower oil, followed by 30 min of sonication 
(Metzger and Chambon, 2001). This emulsion was introduced by i.p. injection.  In 
the first two experiments we injected mice seven times over a 21-day period, and 
in the third experiment we injected the mice eight times over a 16-day period. 
Longer treatments were associated with excessive toxicity (data not shown).  
 
Statistical Analysis  
Statistical analysis was performed using one-sided, unpaired t test, and p 




IL-2 Signals Maintain CD25+CD4+ T Reg Homeostasis and Self-Tolerance  
Previous studies have shown that IL-2 maintains self tolerance by 
increasing the numbers of CD25+CD4+ T regs present in peripheral lymphoid 
organs (Hall et al., 1990; Papiernik et al., 1998; Sakaguchi et al., 1995; Shevach 
et al., 2001; Wolf et al., 2001).  The goal of our study was to define the signaling 
pathways responsible for this function of IL-2.  We started by testing whether IL-2 
signaling was necessary to obtain normal CD25+CD4+ T reg numbers. IL-2, like 
other cytokines that exert their activities by binding to receptors that use the 
common γ-chain, is dependent on the Jak3 kinase to initiate signals (Thomis and 
Berg, 1997).  We, therefore, examined whether mice that were deficient in Jak3 
showed defects in the CD25+CD4+ T reg compartment and in their ability to 
maintain self-tolerance.  Consistent with an essential role for IL-2 signaling in this 
process, we found that the frequency of CD25+CD4+ T regs in the spleen of Jak3 
knockout mice was similar to that in IL-2 and IL-2Rβ knockout mice and was 
reduced compared with that in wild-type mice (Figures 5-1A and 5-2A).  
Furthermore, Jak3 knockout mice exhibited symptoms of autoimmunity, including 
the accumulation of activated CD4+ T cells that were enriched for autoreactive 
cells (Figures 5-1B and 5-2B) (Thomis et al., 1995).  These findings indicated that 
Jak3 signals were required to obtain normal numbers of CD25+CD4+ T regs in 
peripheral lymphoid organs and to maintain self-tolerance.  
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Bcl-2 Is Not a Target of IL-2 Signals that Establish Normal CD25+CD4+ T 
Reg Numbers in the Periphery and Maintain Self-Tolerance  
Since Jak3 is used by many different cytokines to induce signals that 
regulate the development and function of multiple types of immune cells, our next 
goal was to define IL-2-specific signals that were necessary to maintain 
CD25+CD4+ T reg homeostasis. Since other members of the IL-2 cytokine family, 
specifically IL-7 and IL-15, had previously been shown to promote the 
development and maintenance of T cell populations by up-regulating Bcl-2 
(Akashi et al., 1997; Maraskovsky et al., 1997; Wu et al., 2002), we tested 
whether induction of this anti-apoptotic molecule by IL-2 was required to establish 
a normal CD25+CD4+ T reg compartment. To accomplish this we created a strain 
of IL-2-deficient mice that constitutively expressed Bcl-2 in T cells as a transgene.  
In these experiments we used a Bcl-2 transgene that had previously been shown 
to rescue the development of T cells in IL-7R-deficient mice (Maraskovsky et al., 
1997).  We found that the numbers of CD25+CD4+ T regs present in the spleen of 
IL-2-deficient mice were not increased by Bcl-2 expression, nor did expression of 
this molecule prevent the accumulation of activated CD4+ T cells seen in the 
absence of IL-2 (Figure 5-3A) or affect the onset and severity of the autoimmune 
disease (Figure 5-3, B and C).  Indeed, when we compared expression of Bcl-2 in 
mature CD25+CD4+ T regs from wild-type and IL-2-deficient mice by intracellular 
staining with fluorescent Abs, we detected comparable levels of this protein in 
both cell populations (Figure 5-3A).  
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Further supporting the idea that Bcl-2 was not involved in establishing the 
CD25+CD4+ T reg compartment or maintaining self tolerance, we found that Bcl-2 
knockout mice with intact IL-2 activity had normal numbers of CD25+CD4+ T regs 
in the periphery (Figure 5-2A and Table 5-1) and exhibited no signs of 
autoimmunity (Figures. 5-2B and 5-3C).  
 
CD25+CD4+ T Reg Numbers and Function Are Defective in STAT5-Deficient 
Mice, Leading to Deregulated Lymphoid Homeostasis  
Having excluded a role for Bcl-2 as a downstream target of IL-2 signals 
that regulate the CD25+CD4+ T reg compartment, we next examined whether 
activation of STAT5 was required in this process. First, we determined the 
numbers of CD25+CD4+ T regs that were present in the spleens of STAT5-
deficient mice and found that these were significantly reduced compared with 
wild-type controls (Figure 5-2A and Table 5-1). In the thymus, however, STAT5 
knockout mice did not have statistically lower numbers of CD25+CD4+ T regs than 
those found in littermate controls (Table 1).  We had previously seen this pattern 
of normal thymic T reg levels but reduced numbers of peripheral T regs in IL-2 
and IL-2Rβ-deficient mice.  Our findings suggested that STAT5 might be a key 
target of IL-2 signals that control CD25+CD4+ T reg homeostasis.  
We and others have noted that STAT5-deficient mice, like IL-2- and IL-
2Rβ-deficient mice, exhibited defects in lymphoid homeostasis, reflected by the 
accumulation of activated CD4+ T cells and the development of splenomegaly 
(Figure 5-4, A and B) (Teglund et al., 1998).  These symptoms may arise due to a 
 198
defect in the CD25+CD4+ T reg compartment, although previous studies have 
also provided compelling evidence that the accumulation of cells in the spleen of 
STAT5-deficient mice might arise from a defect in erythropoiesis (Socolovsky et 
al., 1999; Socolovsky et al., 2001).  To directly test the contribution of the 
lymphoid compartment to the splenomegaly that develops in STAT5- and IL-2-
deficient mice, we bred mice that lacked these genes with mice that carried a null 
allele of RAG1, which prevents the generation of B and T cells (Mombaerts et al., 
1992; Spanopoulou et al., 1994).  We found that in the absence of lymphocytes, 
both IL-2 and STAT5 knockout mice had similar numbers of splenocytes 
compared with wild-type (RAG1-deficient) mice (Figure 5-4B). The laboratory of 
Dr. J. Ihle has reported similar results in a recent review article (Ihle, 2001).  
To formally test whether the deregulation of lymphoid homeostasis seen in 
STAT5-deficient mice was the result of a defect in regulatory T cells, we injected 
between 0.2 and 0.5 x 106 wild-type CD25+CD4+ T regs into neonatal STAT5 
knockout mice and monitored the development of disease in adult mice. In IL-
2Rβ-deficient mice, this treatment has been found to result in the homeostatic 
expansion of the injected CD25+CD4+ T regs and to block the development of 
autoimmune disease (Malek et al., 2002).  We found that adoptive transfer of 
wild-type CD25+CD4+ T regs into STAT5-deficient mice was sufficient to prevent 
the development of splenomegaly and the accumulation of activated T cells 
(Figure 5-4, A and B), suggesting that these disease symptoms arose due to a 
defect in the regulatory T cells compartment.  
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STAT5 Activation Increases CD25+CD4+ T Reg Numbers in the Absence of 
IL-2  
The results of our experiments with STAT5-deficient mice were consistent 
with a role for this transcription factor as a target of IL-2 signals that regulate the 
T reg compartment.  To test this directly, we examined whether STAT5 activation 
was sufficient to increase CD25+CD4+ T reg numbers in the absence of IL-2.  To 
accomplish this we introduced an active form of STAT5 (Onishi et al., 1998) 
together with GFP as a marker gene in bone marrow stem cells derived from IL-
2-deficient mice using a retrovirus-based expression vector (Van Parijs et al., 
1999b).  These cells were used to reconstitute the immune system of lethally 
irradiated recipient mice (Van Parijs et al., 1999a).  
Complicating these experiments, we found that constitutive expression of 
an active form of STAT5 in hemopoietic stem cells resulted in the development of 
tumors in reconstituted mice (data not shown).  To overcome this problem, we 
engineered an inducible form of STAT5 by fusing an active allele of this molecule 
with a modified version of the binding domain of the estrogen receptor (Littlewood 
et al., 1995).  This conditional allele of STAT5 (STAT5ER) was only active in the 
presence of OHT, an estrogen analog (Littlewood et al., 1995) (Figure 5-5A), and 
allowed us to create IL-2-deficient mice in which we could activate STAT5 
transiently.  We found that the numbers of CD25+CD4+ cells found in the spleen 
of chimeric mice was significantly increased after 2 wk of STAT5 activation 
(Figure 5-5B), and that these cells possessed regulatory activity (Figure 5-5C). 
This effect of STAT5 was cell intrinsic, since we only observed an increase in 
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GFP+ (retrovirus-infected) CD25+CD4+ T regs in these experiments (Figure 5-5B).  
Thus, activation of STAT5 was sufficient to promote CD25+CD4+ T reg numbers 
in the absence of IL-2. Not all CD4+ T cells adopted a T reg fate upon STAT5 
activation (Figure 5-5B), consistent with the idea that other factors play important 
roles in T reg development and the maintenance of these cells (Fontenot et al., 
2003; Khattri et al., 2003). 
 
4. Discussion 
Recent studies have established that IL-2 functions to maintain 
CD25+CD4+ T reg homeostasis (Almeida et al., 2002; Furtado et al., 2002; Malek 
et al., 2002). In this study we have used genetic approaches to investigate the 
contributions of two key IL-2 signaling molecules, Bcl-2 and STAT5, to this 
process.  Our findings demonstrate that CD25+CD4+ T reg homeostasis is not 
dependent on Bcl-2, but that STAT5 activation is required to establish normal T 
reg numbers in the peripheral lymphoid organs of mice. This function of STAT5 is 
necessary to prevent the accumulation of activated CD4+ T cells and to block the 
development of splenomegaly.  Our study identifies a key molecular component 
of the IL-2 signaling pathway that controls T reg homeostasis and the 
maintenance of self tolerance.  
IL-2 and related cytokines, such as IL-7 and IL-15, activate signaling 
pathways that result in cellular proliferation, survival, and differentiation (Nelson 
and Willerford, 1998). Biochemical and genetic analysis of IL-2 signaling in T cell 
lines and primary T cells suggests that activation of STAT5 and the expression of 
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c-Myc are required to induce proliferation, while up-regulation of Bcl-2 family 
molecules is required to promote survival (Nelson and Willerford, 1998). Both IL-
7 and IL-15 have been implicated in the development and homeostasis of specific 
lymphocyte populations, namely immature T cells (and B cells) in the case of IL-7 
(Peschon et al., 1994; Vonfreedenjeffry et al., 1995), and CD8+ T cells in the case 
of IL-15 (Lodolce et al., 1998).  The essential function of these cytokines appears 
to be to promote survival, since the expression of Bcl-2 is reduced in the affected 
T cell populations in the absence of cytokine, Bcl-2 deficiency leads to a 
decrease specifically in CD8+ T cell numbers, and ectopic Bcl-2 expression is 
sufficient to rescue T cells in IL-7R-deficient mice (Akashi et al., 1997; 
Maraskovsky et al., 1997; Wu et al., 2002).  Our results indicate that IL-2 does 
not appear to function in the same manner in CD25+CD4+ T regs.  Bcl-2 is not 
necessary to obtain a normal CD25+CD4+ T reg compartment, and transgenic 
expression of Bcl-2 does not rescue these cells in IL-2-deficient mice.  
Instead, our study demonstrates that CD25+CD4+ T reg homeostasis is 
dependent on the activation of STAT5. STAT5-deficient mice show reduced 
numbers of these cells, and transient activation of STAT5 in IL-2-deficient mice 
increases the numbers of CD25+CD4+ T regs in the periphery.  How STAT5 acts 
in CD25+CD4+ T regs remains to be determined. In conventional T cells, STAT5 
is predominantly responsible for inducing proliferation (Moriggl et al., 1999a; 
Moriggl et al., 1999b).  However, this transcription factor may also function during 
lymphocyte development and is necessary to obtain NK cells (Moriggl et al., 
1999b).  STAT5 has been reported to promote the survival of hemopoietic cells 
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both by stimulating the expression of Bcl-2 family proteins and by triggering Bcl-
2- and Bcl-x-independent survival pathways (Nelson and Willerford, 1998; 
Socolovsky et al., 1999).  Our findings suggest that it is unlikely that STAT5 
functions only to activate a survival signal in CD25+CD4+ T regs.  
Recent gene expression profiling experiments have uncovered that STAT5 
target genes, such as members of the SOCS family of proteins, SOCS1 and -3, 
and cis, are upregulated in CD25+CD4+ T regs compared with conventional T 
cells (McHugh et al., 2002).  SOCS molecules function to inhibit the proliferative 
effects of cytokines and can antagonize STAT5 activity (McHugh et al., 2002; 
Moriggl et al., 1999a).  Whether they also contribute to the anergic state that 
characterizes CD25+CD4+ T regs is not known. STAT5 activation is also 
necessary for high-level expression of CD25 on T cells (McHugh et al., 2002; 
Moriggl et al., 1999a).  This raises the possibility that STAT5 may be activated by 
other cytokines, such as IL-7 (Lin and Leonard, 2000), and function to render 
CD25+CD4+ T regs responsive to IL-2.  Our experiments demonstrate that 
activation of STAT5 in the absence of IL-2 leads to an increase in the number of 
CD25+CD4+ T cells with regulatory activity, but do not formally exclude an 
important role for STAT5 upstream of IL-2.  Indeed, Tg mice bearing a mutant IL-
2R β-chain that fails to activate STAT5 do not develop autoimmunity (Fujii et al., 
1998).  Although the status of CD25+CD4+ T regs was not assessed in these 
mice, this finding does suggest that STAT5 may also act downstream of 
cytokines other than IL-2 to regulate the CD25+CD4+ T reg compartment and T 
cell tolerance.  
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The cellular mechanisms by which IL-2 signals and STAT5 promote 
CD25+CD4+ T reg activity in the mouse remain to be established. In principal, 
they could act to promote the following events: 1) development of CD25+CD4+ T 
cells, 2) activity of CD25+CD4+ T cells, or 3) expansion and homeostasis of 
CD25+CD4+ T cells.  Supporting a role for IL-2 signaling during the development 
of CD25+CD4+ T regs, a recent report demonstrates that the expression of IL-2R 
in the thymus is sufficient to obtain a normal CD25+CD4+ T reg compartment and 
to prevent autoimmune disease (Malek et al., 2002).  However, functional 
CD25+CD4+ T regs have been detected in mice that lack IL-2 or a functional IL-
2R, demonstrating that this cytokine is not essential for the development or 
activity of CD25+CD4+ T regs (Almeida et al., 2002; Furtado et al., 2002).  Recent 
adoptive transfer experiments suggest that IL-2 may also promote the 
persistence of CD25+CD4+ T regs in peripheral lymphoid tissues.  Future studies 
of the cellular consequences of IL-2 and STAT5 signaling in these cells should 













Table 5-1: CD25+CD4+ regulator T cell numbers in mouse strains with defects in 
IL-2 and key IL-2 signaling moleculesa 
 
Genotype No. of Splenic T Regs (x10-6) No. of Thymic T Regs (x10-6) 
Wild-type 2.3 ± 1.0 (n=6) 0.26 ± 0.02 (n=3) 
IL-2 KO 0.4 ± 0.2 (n=4) 0.25 ± 0.06 (n=3) 
STAT5 KO 0.7 ± 0.5 (n=6) 0.32 ± 0.08 (n=6) 
Bcl-2 KO 1.7 ± 0.5 (n=3) N.D. 
a: The numbers of CD25+CD4+ T regs present in the spleen and thymus of 6- to 
8 wk-old wild-type, IL-2 knockout (IL-2 KO), STAT5 knockout (STAT5 KO), and 
Bcl-2 knockout (Bcl-2 KO) C57BL/6 mice was determined by counting and by 
flow cytometry. Average CD25+CD4+ T reg numbers and SD from three to six 











































Figure 5-1: Jak3 is required to establish normal CD25+CD4+ T reg numbers in 
the periphery and to prevent the accumulation of activated CD4+ T cells. The 
frequency of CD25+CD4+ T regs and activated CD4+ T cells present in the spleen 
of wild-type (WT) and Jak3 knockout (JAK3KO) mice (n = 3) was assayed by 
staining and flow cytometry. In these experiments we used forward/side scatter 
profiles to identify live cells and gated on CD4+ cells.  (A) Frequency of 
CD25+CD4+ T regs. Spleen cells were stained with anti-CD4 and anti-CD25. The 
percentages indicate the fraction of CD4+ T cells that were also CD25+.  (B) 
Frequency of activated CD4+ T cells. Spleen cells were stained with anti-CD4 






























Figure 5-2: IL-2 and STAT5, but not Bcl-2, are required to establish normal 
CD25+CD4+ T reg numbers in the periphery and to prevent the accumulation of 
activated CD4+ T cells. The frequency of CD25+CD4+ T regs and activated CD4+ 
T cells present in the spleen of wild-type (WT; n = 25) Bcl-2 knockout (Bcl-2 KO; 
n = 4), IL-2 knockout (IL-2 KO; n = 25), IL-2Rβ knockout (IL-2Rβ KO; n = 3), and 
STAT5 knockout (STAT5 KO; n = 7) mice was assayed by staining and flow 
cytometry.  In these experiments we used forward/side scatter profiles to identify 
live cells and gated on CD4+ cells.  (A) Frequency of CD25+CD4+ T regs. Spleen 
cells were stained with Abs against CD4 and CD25. The percentages indicate 
the fraction of CD4+ T cells that were also CD25+.  (B) Frequency of activated 
CD4+ T cells. Spleen cells were stained with Abs against CD4 and CD62L. 







































Figure 5-3: Tg expression of Bcl-2 does not rescue CD25+CD4+ T reg numbers 
or prevent the accumulation of activated CD4+ T cells and the development of 
splenomegaly in IL-2-deficient mice. The frequency of CD25+CD4+ T regs 
present in the spleen of wild-type (WT; n = 3), IL-2 knockout (IL-2 KO; n = 3), and 
IL-2 knockout mice expressing a Bcl-2 transgene (IL-2 KOxBcl-2Tg; n = 3) was 
assayed. In these experiments we used forward/side scatter profiles to identify 
live cells and gated on CD4+ cells.  (A) Frequency of CD25+CD4+ T regs. Spleen 
cells were stained with Abs against CD4 and CD25. The percentages indicate 
the fraction of CD4+ T cells that were also CD25+.  (B) Frequency of activated 
CD4+ T cells. Spleen cells were stained with Abs against CD4 and CD62L. 
Activated CD4+ T cells were identified as CD4+CD62Llow.  (C) Development of 
splenomegaly. The average weight of spleens from three to five WT, IL-2KO, IL-
2KOxBcl-2Tg, and Bcl-2 knockout (Bcl-2KO) mice was determined. *, p < 0.05 vs 

























Figure 5-4: Adoptive transfer of CD25+CD4+ T regs prevents the development of 
autoimmunity in STAT5-deficient mice. The development of autoimmune 
symptoms was assayed in adult wild-type (WT; n = 6), STAT5 knockout 
(STAT5KO; n = 6), IL-2KO (n = 4), RAG1KO (n = 4), IL-2KOxRAG1KO (n = 4), 
STAT5KOxRAG1KO (n = 6), and STAT5 knockout mice injected neonatally with 
wild-type CD25+CD4+ T regs (n = 6).  (A) Frequency of activated T cells present 
in the spleens of WT, STAT5 KO, and STAT5KO injected with wild-type 
CD25+CD4+ T regs identified by flow cytometry as CD4+CD62Llow cells.  (B) and 
(C) Spleen weight. *, p < 0.001 vs STAT5 KO (A and B), p < 0.001 vs STAT5KO 




















Figure 5-5: Transient activation of STAT5 increases CD25+CD4+ T reg numbers 
in IL-2-deficient mice. The effect of STAT5 signaling on the development of 
CD25+CD4+ T regs in wild-type (WT) and IL-2 knockout (IL-2KO) mice was 
assayed by expressing a conditionally active allele of STAT5 in hemopoietic cells 
of bone marrow chimeras using a retrovirus-based expression system.  (A) 
Creation of a conditionally active allele of STAT5. Activated CD4+ T cells from 
WT mice were infected with a retrovirus (MIG) engineered to express a 
constitutively active allele of STAT5 (CA) or a conditionally active allele of STAT5 
(ER) and were cultured in the presence or the absence of OHT. Proliferation was 
assayed after 48 h by [3H]thymidine incorporation.  (B) Frequency of CD25+CD4+ 
T cells. WT or IL-2KO bone marrow chimeras expressing a control virus (MIG) or 
STAT5ER in 30–50% of all hemopoietic cells were treated for 2–3 wk with OHT 
or vehicle alone (No OHT). As a specificity control, we compared the frequencies 
of CD25+CD4+ T regs within the infected (GFP+) and noninfected (GFP-) CD4+ T 
cell populations. Each data point represents the mean of a group of three mice (n 
= 3).  (C) Regulatory activity of STAT5-expressing CD25+CD4+ T regs from IL-2-
deficient mice. CD4+CD25+GFP+ cells (○ and ●) or CD4+CD25-GFP+ cells (■) 
were purified from the spleens of OHT-treated IL-2KO mice (○) or wild-type mice 
(■) and cultured at increasing cell numbers with 100,000 conventional CD4+ 
(CD25-) T cells in the presence of anti-CD3 and irradiated whole splenocytes. 
Proliferation was assayed after 72 h by [3H]thymidine incorporation. *, p < 0.025 
vs GFP- control. 
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